Skip to main content
. Author manuscript; available in PMC: 2014 Sep 26.
Published in final edited form as: Cancer. 2010 Nov 8;117(7):1478–1489. doi: 10.1002/cncr.25654

Table 2.

Comparison of Patient Tumor and TLBR-1 Cell Line to Primary Systemic, Primary Cutaneous, and Seroma-Associated ALCLs

Primary Systemic ALCL Primary Cutaneous ALCL Seroma- Associated ALCL Primary Tumor Specimen TLBR-1 Cell Line & SCID Heterotransplant
CD30 + + + + +
TCRγ monoclonality + + + + +
ALK + (60–80%) − (Rarely +) − (Rarely +)
t(2;5) + (60–80%)
EMA + + + Weak
Clinical course Aggressive Indolent Indolent Indolent NA